Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Herpes simplex virus-1 targets the 2′-3'cGAMP importer SLC19A1 as an antiviral countermeasure

Virology(2024)10.1016/j.virol.2024.110320Source: DataRank Database

Herpes simplex virus-1 targets the 2′-3'cGAMP importer SLC19A1 as an antiviral countermeasure is a research paper published in Virology (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.83)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Emmanuel C. Ijezie ORCID,Eain A. Murphy ORCID,Zsuzsa K Szemere

Live enrichment

PubMed:39637474 PMC:PMC11839204 OpenAlex:https://openalex.org/W4404876441

National Institute on Aging

Grant: 5R01AG076007

National Institute of Allergy and Infectious Diseases Division of Intramural Research

Grant: 5R01AI155979

NIA NIH HHS

Grant: R01 AG076007

NIAID NIH HHS

Grant: R01 AI155979

National Institutes of Health

FWCI

0.83

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11839204/pdf/nihms-2051712.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0042682224003441?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0042682224003441?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11839204

Fields of Study

Herpesvirus Infections and Treatmentsinterferon and immune responsesCytomegalovirus and herpesvirus researchHerpesvirus 1, HumanHumansVirus ReplicationHerpes SimplexImmediate-Early ProteinsAntiviral AgentsAntiportersAnimalsChlorocebus aethiopsHEK293 CellsVero CellsHost-Pathogen InteractionsCell Line

MeSH Terms

AnimalsAntiviral AgentsCell LineChlorocebus aethiopsHerpes SimplexHumansMembrane ProteinsVero CellsVirus ReplicationImmediate-Early ProteinsAntiportersHerpesvirus 1, HumanHost-Pathogen InteractionsHEK293 CellsReduced Folate Carrier Protein

Keywords

BiologyHerpes simplex virusVirusViral replicationVirologyImmune systemCell biologyInnate immune systemImmunologyHerpesvirusHSV-1Slc19a1StingIcp27

Herpes simplex virus-1 targets the 2′-3'cGAMP importer SLC19A1 as an antiviral countermeasure

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)